Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moskovitz

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Clinical Gastroenterology|April 25, 2000
Primary peritonitis due to group A streptococcusM Moskovitz, E Ehrenberg, R Grieco, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 29, 2020
Clinical activity of brigatinib in ROS1-rearranged non-small cell lung cancerE Dudnik, A Agbarya, R Grinberg, et al.
Current Oncology (Toronto, Ont.)|February 28, 2013
Conservative management for an entero-adnexal fistula at initial presentation of advanced ovarian carcinomaA Shai, E Grikshtas, Y Segev, et al.
Digestive Diseases and Sciences|October 1, 1979
Diet, fecal bile acids, and neutral sterols in carcinoma of the colonM Moskovitz, C White, R N Barnett, et al.
The Laryngoscope|June 9, 2021
The Nasoseptal Flap for Reconstruction of Lateral Oropharyngectomy Defects: A Clinical SeriesMeghan T Turner, Mathew N Geltzeiler, Jad Ramadan, et al.
Thrombosis Research|June 9, 2026
Novel germline genetic variants associated with venous thrombo-embolism (VTE) and arterial thrombo-embolism (ATE) risk in patients with ALK and ROS1 fusion non-small cell lung cancer (NSCLC)S Khan, B Jimenez Munarriz, K Hueniken, et al.
Current Oncology (Toronto, Ont.)|January 4, 2020
Combined cancer patient-reported symptom and health utility tool for routine clinical implementation: a real-world comparison of the ESAS and EQ-5D in multiple cancer sitesM Moskovitz, K Jao, J Su, et al.
Science Immunology|July 19, 2020
Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 sheddingLawrence P Andrews, Ashwin Somasundaram, Jessica M Moskovitz, et al.
Cell|May 30, 2017
Interferon-γ Drives T<sub>reg</sub> Fragility to Promote Anti-tumor ImmunityAbigail E Overacre-Delgoffe, Maria Chikina, Rebekah E Dadey, et al.
ESMO Open|June 4, 2024
Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-RA R Filippi, J Bar, C Chouaid, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Clinical Gastroenterology|April 25, 2000
Primary peritonitis due to group A streptococcusM Moskovitz, E Ehrenberg, R Grieco, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 29, 2020
Clinical activity of brigatinib in ROS1-rearranged non-small cell lung cancerE Dudnik, A Agbarya, R Grinberg, et al.
Current Oncology (Toronto, Ont.)|February 28, 2013
Conservative management for an entero-adnexal fistula at initial presentation of advanced ovarian carcinomaA Shai, E Grikshtas, Y Segev, et al.
Digestive Diseases and Sciences|October 1, 1979
Diet, fecal bile acids, and neutral sterols in carcinoma of the colonM Moskovitz, C White, R N Barnett, et al.
The Laryngoscope|June 9, 2021
The Nasoseptal Flap for Reconstruction of Lateral Oropharyngectomy Defects: A Clinical SeriesMeghan T Turner, Mathew N Geltzeiler, Jad Ramadan, et al.
Thrombosis Research|June 9, 2026
Novel germline genetic variants associated with venous thrombo-embolism (VTE) and arterial thrombo-embolism (ATE) risk in patients with ALK and ROS1 fusion non-small cell lung cancer (NSCLC)S Khan, B Jimenez Munarriz, K Hueniken, et al.
Current Oncology (Toronto, Ont.)|January 4, 2020
Combined cancer patient-reported symptom and health utility tool for routine clinical implementation: a real-world comparison of the ESAS and EQ-5D in multiple cancer sitesM Moskovitz, K Jao, J Su, et al.
Science Immunology|July 19, 2020
Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 sheddingLawrence P Andrews, Ashwin Somasundaram, Jessica M Moskovitz, et al.
Cell|May 30, 2017
Interferon-γ Drives T<sub>reg</sub> Fragility to Promote Anti-tumor ImmunityAbigail E Overacre-Delgoffe, Maria Chikina, Rebekah E Dadey, et al.
ESMO Open|June 4, 2024
Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-RA R Filippi, J Bar, C Chouaid, et al.
Pageof 5